Initiating Honey Bee Venom Immunotherapy at the 100-µg Maintenance Dose versus Ultrarush Up-dosing: A Randomised Pilot Safety Study

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2026
This article has no abstract
Epistemonikos ID: 8b43479f5bb48c66394f9acabc978ad0d4fe6715
First added on: Apr 28, 2026